Skip to main content
SpringerLink
Log in

This Month’s News

  • Published:
Disease Management and Health Outcomes

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was sponsored by LifeScan, Inc., US, which has licences on some of the behavioural change methods used.

  2. Stages of change were based the Prochaska model of change.

  3. One of the authors was affiliated with Pfizer, Inc., USA.

  4. Costs included those associated with the immunization initiative (including advertisements, Internet start-up costs, providers, vaccines and supplies), medical care for vaccination-related adverse events, medical care avoided, work loss due to time away for vaccination and vaccination-related adverse events, and work loss avoided.

  5. The study was supported in part by a grant from Merck Frosst Canada & Co.

  6. The composite endpoint comprized performance of a fasting cholesterol panel, prescription of an antihyperlipidemic agent or an increase in the dosage of an antihyperlipidemic agent.

  7. Costs (1999 Canadian dollars) calculated from the provincial government perspective included those for physician visits, antihyperlipidemic therapy, emergency-department visits, cholesterol profiling and lipid function tests; those from the community pharmacy manager perspective included those for equipment and supplies and pharmacist training and time.

  8. American College of Gastroenterology guidelines.

  9. Will Pfizer/Florida deal be the first of many?

  10. Pfizer’s Florida deal ensures Medicaid access.

References

Reference

  • Medicaid may tap Pfizer to manage four DM programs. Dis Manage News 2001 Jun 10; 6: 1 & 5

Reference

  • Jones J, Cronin JM. The pros and cons of formularies. J Managed Care Pharm 2000 May–Jun; 6: 203–7

    Google Scholar 

Reference

  • Caremark Rx Inc. Caremark’s CarePatterns (R) diabetes disease-management program reduces total healthcare costs, improves quality of life for diabetics. Media release: [2 pages], 2001 Jul 17. Available from: URL: http://www.caremarkrx.com

Reference

  • Pain management DM starting to catch on, ProCare says. Dis Manage News 2001 Jun 25; 6: 8

Reference

  • Study shows behavior interventions alone can aid diabetics. Dis Manage News 2001 Jul 10; 6: 2–3

    Google Scholar 

Reference

  • VISN 8 reports 74% cost drop with Health Hero. Dis Manage News 2001 Jul 25; 6: 2

Reference

  • Texas medical privacy law poses few concerns for DM industry. Dis Manage News 2001 Jul 10; 6: 2

    Google Scholar 

Reference

  • Sias JJ, Cook S, Wolfe T, et al. An employee influenza immunization initiative in a large university managed care setting. J Managed Care Pharm 2001 May-Jun; 7: 219–23

    Google Scholar 

Reference

  • Pharmaceutical Care Network. Pharmaceutical Care Network innovations, service halt rising drug spend; promote quality patient care. Media release: [2 pages], 2001 Jul 25

Reference

  • Simpson SH, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists. Pharmacotherapy 2001 May; 21: 627–35

    Article  PubMed  CAS  Google Scholar 

References

  1. Will Pfizer/Florida deal be the first of many? Marketletter 2001 Jul 16; 28: 14

  2. Pfizer’s Florida deal ensures Medicaid access. Scrip 2001 Jul 23; 2660: 15

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

This Month’s News. Dis-Manage-Health-Outcomes 9, 517–521 (2001). https://doi.org/10.2165/00115677-200109090-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200109090-00006

Search

Navigation